Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
anti-SARS-CoV-2 Spike Protein S1, mAb (rec.) (blocking) (Covi-2) (preservative free)
370
CHF
CHF 370.00
In stock
AG-27B-6006PF-C100100 µgCHF 370.00
Figure 1: Binding of human ACE2 to the Spike protein of SARS-CoV-2 is inhibited by the antibody SARS-CoV-2 Spike Protein S1, mAb (rec.) (blocking) (Covi-2) (preservative free) (Prod. No. AG-27B-6006PF).
Methods: SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (Prod. No. AG-40B-0194) is coated on an ELISA plate at 1µg/ml. SARS-CoV-2 Spike Protein S1, mAb (rec.) (blocking) (Covi-2) (preservative free) (Prod. No. AG-27B-6006PF) or an unrelated recombinant mAb (Control) is added (starting at 40µg/ml with a two-fold serial dilution) together with 500ng/µl of ACE2 (human) (rec.) (Biotin) (Prod. No. AG-40B-0192B). After incubation for 1h at 37°C, the binding is detected using Streptavidin (HRP).
Methods: SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (Prod. No. AG-40B-0194) is coated on an ELISA plate at 1µg/ml. SARS-CoV-2 Spike Protein S1, mAb (rec.) (blocking) (Covi-2) (preservative free) (Prod. No. AG-27B-6006PF) or an unrelated recombinant mAb (Control) is added (starting at 40µg/ml with a two-fold serial dilution) together with 500ng/µl of ACE2 (human) (rec.) (Biotin) (Prod. No. AG-40B-0192B). After incubation for 1h at 37°C, the binding is detected using Streptavidin (HRP).
Figure 2: ELISA binding assay with SARS-CoV-2 S1 Protein (RBD) (rec.) (His) (Pord. No. CHI-B232004) using anti-SARS-CoV-2 Spike Protein S1, mAb (rec.) (Covi-2) (preservative free) (#AG-27B-6006PF) (blue line) and an unrelated antibody as negative control (red line).
| Product Details | |
|---|---|
| Synonyms | 2019-nCoV Spike Protein S1 |
| Product Type | Recombinant Antibody |
| Properties | |
| Clone | Covi-2 |
| Isotype | Human IgG1 |
| Source/Host | HEK 293 cells |
| Immunogen/Antigen | Recombinant SARS-CoV-2 Spike Protein S1 receptor binding domain. |
| Label/Conjugates | Preservative Free |
| Application |
ELISA Binding Assay Functional Application: Blocking Western Blot: Works only in non-denatured conditions (1/1’000). |
| Crossreactivity | Virus |
| Specificity |
Recognizes and binds to recombinant SARS-CoV-2 Spike Protein S1. It blocks the interaction of SARS-CoV-2 Spike Protein S1 (RBD) to human ACE2. Detects a different epitope as anti-SARS-CoV-2 Spike Protein S1, mAb (rec.) (blocking) (Covi-1) (Prod. No. AG-27B-6005PF). |
| Purity | ≥98% (SDS-PAGE) |
| Purity Detail | Protein A purified. |
| Endotoxin Content | <0.001EU/μg |
| Concentration | 1mg/ml |
| Formulation | Liquid. In PBS. |
| Isotype Negative Control | |
| Other Product Data |
Uniprot P0DTC2: SARS-CoV-2 |
| Accession Number | P0DTC2 |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Avoid freeze/thaw cycles. |
| Use/Stability | Stable for at least 1 year after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
Coronaviruses (CoVs) are enveloped non-segmented positive-sense single-stranded RNA viruses and can infect respiratory, gastrointestinal, hepatic and central nervous system of human and many other wild animals. Recently, a new severe acute respiratory syndrome β-coronavirus called SARS-CoV-2 (or 2019-nCoV) has emerged, which causes an epidemic of acute respiratory syndrome (called coronavirus human disease 2019 or COVID-19).
SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. SARS-CoV-2 contains 4 structural proteins, including Envelope (E), Membrane (M), Nucleocapsid (N) and Spike (S), which is a transmembrane protein, composed of two subunits S1 and S2. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor Angiotensin-Converting Enzyme 2 (ACE2) present at the surface of epithelial cells, causing mainly infection of human respiratory cells.
Related Products
